# OnCo record neogene-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/neogene-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "neogene-therapeutics" ;
  schema:name "Neogene Therapeutics"@en ;
  schema:description "Neogene developed T-cell receptor therapies that can recognise cancer-specific mutations hidden inside tumour cells, an approach aimed at solid tumours. AstraZeneca bought the company in January 2023 for up to $320 million."@en ;
  schema:url <https://onco.cc/companies/neogene-therapeutics/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/901832/000165495422015806/a9015h.htm>, <https://www.sec.gov/Archives/edgar/data/901832/000165495423000484/a7540m.htm>, <https://www.sec.gov/Archives/edgar/data/901832/000165495422015806/a9015h.htm> ;
  schema:addressCountry "NL" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/> .